ECG Criteria for Left Ventricular Hypertrophy in Hypertensive Black Africans: Insights from the coArtHA Trial

Annina S Vischer1,2, Valeriya Nemtsova1, Blaise Lukau3

  • 1Medical Outpatient Department and Hypertension Centre, ESH Hypertension Centre of Excellence, University Hospital Basel, Basel, Switzerland.

Global Heart
|July 25, 2026
PubMed

Insights

Electrocardiogram (ECG) criteria for left ventricular hypertrophy (LVH) showed moderate accuracy in Black African adults with hypertension. Cornell voltage product measures performed best, but population-specific evaluations are needed for optimal diagnosis.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Public Health

Background:

  • Established electrocardiogram (ECG) criteria for left ventricular hypertrophy (LVH) are primarily based on non-African populations.
  • Their accuracy in Black African adults with untreated hypertension is not well-established.

Purpose of the Study:

  • To assess the diagnostic performance of existing ECG-LVH criteria against echocardiography-derived left ventricular mass index (LVMI).
  • To evaluate these criteria in Black African adults with untreated, uncomplicated hypertension within the coArtHA trial.

Main Methods:

  • Included 1,125 participants from Tanzania and Lesotho undergoing baseline ECG and focused transthoracic echocardiography (fTTE).
  • Left ventricular hypertrophy (LVH) defined by LVMI thresholds (women: >95 g/m², men: >115 g/m²).
  • Diagnostic performance evaluated using correlation, sensitivity, specificity, ROC, AUROC, and PRC analyses.

Main Results:

  • Echocardiographic LVH detected in 5% of participants.
  • Cornell voltage product (adjusted for sex) showed the strongest correlation with LVMI (rho=0.37, p<0.001).
  • Cornell voltage product-based criteria yielded the most consistent performance (AUROC ~0.76), with 64% sensitivity and 80% specificity at established cut-offs. Other criteria showed limited accuracy.

Conclusions:

  • ECG criteria demonstrated moderate association with LVMI in this cohort.
  • Cornell voltage product-based measures showed the most consistent diagnostic performance among evaluated ECG criteria.
  • Findings highlight the need for population-specific validation of ECG criteria for LVH in African populations, considering cut-off selection and clinical context.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...